Wilex raises EUR30 million

Wilex (Munich, Germany), a developer of cancer therapeutics, raised EUR30 million ($26 million) in a venture financing. Investors included TVM; Merlin; Julius Baer; Vontobel; BioConnect; Apax; and Ear...